John Wiesman, Washington state's health secretary, on Monday said the federal government needs to launch a national campaign similar to the one it launched against smoking to combat misinformation about childhood vaccinations, in today's bite-sized hospital and health industry news from Missouri, Nevada, and Washington.
FDA Commissioner Scott Gottlieb sent waves through Capitol Hill and the health care industry on Tuesday when he announced he will resign from his position within the next month. As Heather Bell writes for the Daily Briefing, Gottlieb had largely overcome initial criticism to establish himself as the rare Trump official who garnered support from policymakers on both sides of the aisle.
As the ride-sharing service Lyft gears up for its initial public offering, it's offering investors a sneak peek into its closely held plans to expand its role in health care. Here's how Lyft is already partnering with providers and industry stakeholders—and what could be coming next.
FDA on Tuesday approved a nasal spray antidepressant derived from the anesthetic ketamine to treat adults with severe depression who do not respond to other treatments, but the agency included a boxed warning on the drug and has stipulated that it can only be administered in a health care facility.
Senate Finance Committee Chair Chuck Grassley (R-Iowa) last month renewed his investigation into whether nonprofit hospitals are meeting uncompensated care and other requirements for tax exemptions—a standard Melinda Hatton, general counsel for the American Hospital Association (AHA), said the organization is confident nonprofit hospitals are meeting.
Engaging your staff can be difficult when things are going well. It's even harder—and more important—when things aren't all "sunshine and roses." Advisory Board's Craig Pirner shares four ways to prepare to have an honest conversation with your staff about hard news.
Children who received the measles-mumps-rubella vaccine did not have a higher risk of developing autism than children who did not receive the vaccine, according to a study published Monday—adding to the body of evidence debunking unfounded claims that there is an association between the measles-mumps-rubella vaccine and developing autism.
Print All Daily Briefing Article from
03/06/2019
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
